Dowling & Yahnke’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-815
Closed -$114K 294
2019
Q4
$114K Buy
+815
New +$107K 0.01% 303

Other funds holding BBH

Dowling & Yahnke's BBH Position: Q1 2020 in Review

Dowling & Yahnke sold out of VanEck Biotech ETF (BBH) in Q1 2020, closing a stake of 815 shares — an estimated $114K sold.

Dowling & Yahnke first reported a position in BBH in Q4 2019 and held it in 1 quarter. The position peaked at $114K in Q4 2019. 83 funds tracked by Wall St. Rank hold BBH as of Q1 2020.

  • Dowling & Yahnke reported no remaining VanEck Biotech ETF position as of Q1 2020 after selling out during the quarter.
  • Dowling & Yahnke sold 815 VanEck Biotech ETF shares in Q1 2020, an estimated $114K.
  • Dowling & Yahnke first reported a position in VanEck Biotech ETF in Q4 2019 and held it in 1 quarter.
  • Dowling & Yahnke's VanEck Biotech ETF position peaked at $114K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2020.

Based on Dowling & Yahnke's 13F filing for Q1 2020, filed 15 May 2020.